BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33362700)

  • 1. Case Report: Innate Immune System Challenge Unleashes Paraneoplastic Neurological Autoimmunity.
    Zhu M; Ma Y; Zekeridou A; Lennon VA
    Front Neurol; 2020; 11():598894. PubMed ID: 33362700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
    Chatterjee M; Hurley LC; Tainsky MA
    Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.
    Popkirov S; Ayzenberg I; Hahn S; Bauer J; Denno Y; Rieckhoff N; Radzimski C; Hans VH; Berg S; Roghmann F; Noldus J; Bien CG; Skodda S; Wellmer J; Stöcker W; Krogias C; Gold R; Schlegel U; Probst C; Komorowski L; Miske R; Kleiter I
    Acta Neuropathol Commun; 2017 May; 5(1):40. PubMed ID: 28554330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy.
    Valencia-Sanchez C; Zekeridou A
    Front Neurol; 2021; 12():642800. PubMed ID: 33897597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy.
    Zekeridou A; Lennon VA
    Mayo Clin Proc; 2019 Sep; 94(9):1865-1878. PubMed ID: 31358366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onconeural versus paraneoplastic antigens?
    Eichmüller SB; Bazhin AV
    Curr Med Chem; 2007; 14(23):2489-94. PubMed ID: 17979702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis.
    Zekeridou A; Griesmann GE; Lennon VA
    Muscle Nerve; 2018 Oct; 58(4):600-604. PubMed ID: 29742813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.
    Yshii LM; Gebauer CM; Pignolet B; Mauré E; Quériault C; Pierau M; Saito H; Suzuki N; Brunner-Weinzierl M; Bauer J; Liblau R
    Brain; 2016 Nov; 139(11):2923-2934. PubMed ID: 27604307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
    Storstein A; Vedeler CA
    Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].
    Ovadia H; Karussis D; Abramsky O
    Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paraneoplastic neurological syndrome and autoantibodies].
    Hayashi Y; Inuzuka T
    Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.
    Sculier C; Bentea G; Ruelle L; Grigoriu B; Coureau M; Gorham J; Sideris S; Holbrechts S; Lafitte JJ; Meert AP; Durieux V; Berghmans T; Sculier JP
    Lung Cancer; 2017 Sep; 111():164-175. PubMed ID: 28838389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
    Zekeridou A; Majed M; Heliopoulos I; Lennon VA
    Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and management of paraneoplastic neurological syndromes].
    Saji E; Kawachi I; Nishizawa M
    Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles.
    Ruelle L; Bentea G; Sideris S; El Koulali M; Holbrechts S; Lafitte JJ; Grigoriu B; Sculier C; Meert AP; Durieux V; Berghmans T; Sculier JP
    Lung Cancer; 2017 Sep; 111():150-163. PubMed ID: 28838388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing paraneoplastic neurological disorders.
    de Beukelaar JW; Sillevis Smitt PA
    Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic syndromes affecting the nervous system.
    Dalmau JO; Posner JB
    Semin Oncol; 1997 Jun; 24(3):318-28. PubMed ID: 9208887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.